Vivos Therapeutics VVOS
NASDAQ VVOS
$0.18 +0.01 (+5.39%)
As of: Sep 10, 2026 · 1:19 PM EDT

Vivos Therapeutics (VVOS) EBT Margin (2020 - 2026)

Vivos Therapeutics' (VVOS) quarterly EBT Margin came in at 107.18% in Q2 2026, up 2405.0% year-over-year from 4.28% in Q2 2025, and up 28.91% quarter-over-quarter from 150.77% in Q1 2026.

Analysis

Vivos Therapeutics (VVOS) EBT Margin (2020 - 2026) Analysis & Trends

Vivos Therapeutics (VVOS) has reported EBT Margin for 7 consecutive years, with 107.18% the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EBT Margin rose 2405.0% year-over-year to 107.18% in Q2 2026; TTM through Jun 2026 was 122.62%, a 2273.0% decrease from a year earlier, with the FY2025 full-year figure at 121.71%, down 4724.0% from the prior year.
  • EBT Margin was 107.18% for Q2 2026 at Vivos Therapeutics, up from 150.77% in the prior quarter.
  • Over five years, EBT Margin peaked at 44.15% in Q1 2023 and troughed at 181.85% in Q4 2025.
  • A 5-year average of 115.73% and a median of 128.05% in 2022 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin jumped 11522 bps in 2024 and slumped 10384 bps in 2025, its largest moves.
  • Over 5 years, EBT Margin stood at 156.68% in 2022, then grew by 15 bps to 132.45% in 2023, then surged by 41 bps to 78.02% in 2024, then plunged by 133 bps to 181.85% in 2025, then surged by 41 bps to 107.18% in 2026.
  • The last three EBT Margin figures came in at 107.18% (Q2 2026), 150.77% (Q1 2026), and 181.85% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Align Technology 10.67 Bn 9.57 Bn 757.43 Mn 14.08%
2 Envista Holdings 4.20 Bn 3.07 Bn 407.00 Mn 10.18%
3 Dentsply Sirona 2.10 Bn 1.87 Bn 493.00 Mn 8.02%
4 Milestone Scientific 34.60 Mn 31.98 Mn 1.56 Mn -38.85%
5 Dror Ortho-Design 9.77 Mn 9.68 Mn - -
6 Vivos Therapeutics 3.18 Mn 1.38 Mn 2.95 Mn -107.18%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -107.18%
Mar 31, 2026 -150.77%
Dec 31, 2025 -181.85%
Sep 30, 2025 -79.61%
Jun 30, 2025 -131.23%
Mar 31, 2025 -128.12%
Dec 31, 2024 -78.02%
Sep 30, 2024 -67.77%
Jun 30, 2024 -47.61%
Mar 31, 2024 -110.06%
Dec 31, 2023 -132.45%
Sep 30, 2023 -63.41%
Jun 30, 2023 -162.83%
Mar 31, 2023 -44.15%
Dec 31, 2022 -156.68%
Sep 30, 2022 -127.98%
Jun 30, 2022 -167.11%
Mar 31, 2022 -146.30%
Dec 31, 2021 -168.68%
Sep 30, 2021 -119.95%